About the Company
We do not have any company description for Minerva Neurosciences, Inc. at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $NERV News
NERV Stock Earnings: Minerva Neurosciences Beats EPS for Q1 2024
NERV stock results show that Minerva Neurosciences beat analyst estimates for earnings per share the first quarter of ...
Minerva Neurosciences Inc
Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of a portfolio of product candidates to treat central nervous ...
Minerva Neurosciences: Q1 Earnings Snapshot
BURLINGTON, Mass. (AP) — BURLINGTON, Mass. (AP) — Minerva Neurosciences Inc. (NERV) on Wednesday reported a loss of $8.6 million in its first quarter. On a per-share basis, the Burlington, ...
Minerva Neurosciences Inc NERV
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Minerva Neurosciences, Inc. (NERV)
Overall score is calculated based on proprietary scores based on sector averages in key company indicators: fair value, dividends, innovation, hiring, and insider sentiment. Note: if you don't see ...
Minerva Neurosciences, Inc Common Stock (NERV)
*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change. **Green highlights the top performing ETF by % change in the past ...
Minerva Neurosciences Inc NERV
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Minerva Neurosciences Inc.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Loading the latest forecasts...